Sorry for not responding earlier, was busy with watching some of my stocks taking dives. They're back but man it was scary.
As of those analyst numbers, "1998 -1.36, 1999 -0.453, 2000 0.745, 2001 1.34", they are just as good as previous DEPO analyst projections. Data indicate that Depotech has always been analyzed by idiots or conspirators (chose one), evidenced by the consistently and correspondingly wrong projections with numbers totally off. How would they do this without a viable product? Complete nonsense.
Nevertheless, I believe their technology is a pretty interesting idea. Unfortunately, nothing more yet. It may be worth $ 3-4 million. If someone buys DEPO, kicks out the incompetent management, and takes advantage of the technology - see similar stories -, this could be quite an interesting little company. Watch when the stock dips well below $1, as Bob Barels foresaw it, very clearly, early spring. Then it might be worth buying, depending on the outcome of the class action lawsuit. Depo, with the number of outstanding shares, could be a good target for buyout at around $0.30/share. A good basic team, after some fresh or original brain enhancement, could make some very interesting new drugs (forget the looser Depocyt and Depomorphine). |
